Doctor on the team will be boost for test kit firm

Mar 17 2008 by Andrew Mernin, The Journal

Dr Bidlingmaier’s legacy

The partnership between IDS and Dr Bidlingmaier - a world-renowned player in the growth hormone detection field - could be a major coup for the South Tyneside business.

His technological breakthroughs have been harnessed by the Olympic Games and the Winter Olympics and he continues to be a world leader in his area of expertise. 

Speaking after signing up to partner IDS, he said: "“With the development of these new assays we are focusing on improving the specificity and accuracy of the diagnostic testing. This will give the diagnostic laboratories and pharmaceutical companies new applications and more reliable tools for monitoring patients under treatment.”

Dr. Bidlingmaier is Head of the Endocrine Research Laboratories at the Medizinische Klinik – Innenstadt (Medical Department), Klinikum der Universität, Ludwig-Maximilians University, Munich, Germany.

He graduated from medical School in 1993, received training in internal medicine at the Red-Cross Hospital, Munich, in basic sciences and clinical chemistry at the Neuroendocrine and Clinical Laboratories at the Medizinische Klinik – Innenstadt, and in microbiology at the Max-von-Pettenkofer Institute, Ludwig-Maximilians University, Munich, Germany.

He received his medical education with a main focus on Endocrinology under Professor Christian Strasburger, one of the leading opinion leaders in the field of Growth Research.

His main clinical and research interest is pathophysiology and biochemistry of pituitary and adrenal diseases. His Endocrine Research Laboratory serves many multi-central clinical studies for the pharmaceutical industry.

He has eminent experience in the development of specific antibodies for immunoassays and the development of immunoassays in the field of growth and hypertension.